EMEA-001659-PIP01-15-M06
Key facts
| Invented name |
Crysvita
|
| Active substance |
Burosumab
|
| Therapeutic area |
Other
|
| Decision number |
P/0411/2022
|
| PIP number |
EMEA-001659-PIP01-15-M06
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of X-linked hypophosphataemia
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Kyowa Kirin Holdings B.V.
Tel. +44 (0)1896 664000 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|